"A lot of us need to be better at that, 'cause we'reI'ma go, go, go, go," Kelly said
Sources: Doopedia, Glutathione / Nerochem Res
Here are the key details: Start date: July 1, 2026 End date: December 31, 2027 (unless extended by Congress) Eligible medications: FDA-approved anti-obesity medications, including Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) Patient cost: Flat $50 per month copay Deductible: Waived - the Part D deductible does not apply to medications obtained through this program Prior authorization: Required by most Part D plans, but criteria are standardized under the program The bridge structure is important to understand
Reassess after 12 weeks
So the thing is you're going to plateau on the scale
Patients should also avoid any source that ships "research" tirzepatide for self-use, refuses to identify the pharmacy, sells without a prescription, or asks the patient to choose their own dose without medical review